#DiabetesCare #PrecisionMedicine #MetabolicHealth #LowerTheDose #HealthcareInnovation To view or add a comment, sign in In our recent publication in Diabetes, Obesity and Metabolism, together with Professors Kokkinos and le Roux, we articulate a perspective grounded in robust scientific evidence, yet one that is rarely expressed with candor in the public scientific discourse: that, as with any other chronic disease, pharmacotherapy should constitute the central pillar in the treatment of obesity, while other approaches retain an important but complementary role
Contains the new BioGlute Complex
Therefore, this study aimed to evaluate the protective effects of crocin and pentoxifylline (PTX), administered individually or in combination, against ACRinduced hepatotoxicity in an animal model
The most frequently reported side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain
Endoscopy of Melanosis Coli